What is your preferred first line treatment regimen for patients with untreated transplant-ineligible MM?  

Do you opt for VRd, DaraRD, CyBorD or another regimen? 

How would this change for a patient with high risk cytogenetics?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at The Christ Hospital Network
Great summary. I am more inclined to incorporate D...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at The Christ Hospital Network
There is more data for four-drug regimen induction...
Sign in or Register to read more